Compass Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
9.26
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
4
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.12
|
0.00
|
0.12
|
100.00%
|
|
2022-12-31
|
-0.11
|
0.00
|
0.11
|
100.00%
|
|
2022-09-30
|
-0.11
|
-0.12
|
-0.01
|
-9.09%
|
|
2022-06-30
|
-0.08
|
-0.08
|
0.00
|
0.00%
|
|
2022-03-31
|
-0.11
|
-0.07
|
0.04
|
36.36%
|
|
2021-12-31
|
-0.07
|
-0.21
|
-0.14
|
-200.00%
|
|
2021-09-30
|
-0.12
|
-0.10
|
0.02
|
16.67%
|
|
2021-06-30
|
0.00
|
-1.07
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.27
|
|
2021-12-31
|
-1.52
|
|
2020-12-31
|
-0.93
|
|
2019-12-31
|
-4.45
|